BioCentury
ARTICLE | Clinical News

Brivaracetam: Phase III data

July 28, 2014 7:00 AM UTC

Top-line data from the double-blind, international Phase III N01358 trial in 768 epilepsy patients showed that adjunctive treatment with once-daily 100 and 200 mg brivaracetam for 12 weeks each met th...